Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Support

This activity is supported by educational grants from AstraZeneca; Daiichi Sankyo, Inc.; Genomic Health, Inc.; Gilead Sciences, Inc.; Merck & Co., Inc.; and Sanofi Genzyme.

School of Breast Oncology® Live Video Webcast: Clinical Updates from Chicago

Release Date: September 8, 2021
Expiration Date: September 8, 2022

Activity Overview

This online, on-demand virtual symposium brings together renowned experts in treatment of breast cancer. In this educational program, these experts provide a comprehensive overview of noteworthy data presented at the international society meeting held virtually from Chicago in June 2021. Topics include current and novel treatment options for patients with early-stage and metastatic disease as well as locoregional control with surgery and radiation.

This educational activity is an archive of the live virtual symposium held on August 26, 2021.

Acknowledgement of Commercial Support

This activity is supported by educational grants from AstraZeneca; Daiichi Sankyo, Inc.; Genomic Health, Inc.; Gilead Sciences, Inc.; Merck & Co., Inc.; and Sanofi Genzyme.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This activity is directed toward medical oncologists who treat patients with breast cancer. Fellows, nurses, nurse practitioners, physician assistants, and other healthcare professionals involved in the management of breast cancer are also invited to participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Explain key efficacy and safety outcomes from recent clinical trials conducted among patients with breast cancer
  • Consider the relevance of landmark clinical trial findings in the context of how this evidence can be practically incorporated into evolving breast cancer treatment paradigms
  • Discuss ongoing clinical trials designed to answer important clinical questions in the field of breast cancer treatment

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible entities.


Joyce O'Shaughnessy, MD
Joyce O'Shaughnessy, MD
Celebrating Women Chair in Breast Cancer Research
Chair, Breast Cancer Prevention Research
Co-chair, Breast Cancer Research Program
Baylor University Medical Center
Texas Oncology/US Oncology Network
Dallas, TX

Disclosures: Consultant: AbbVie Inc., Agendia Precision Oncology, Amgen, AstraZeneca, Bristol Meyers Squibb, Celgene Corporation, Eisai, Genentech, Genomic Health, GRAIL, Heron Therapeutics, Immunomedics, Ipsen Biopharmaceuticals, Jounce Therapeutics, Lilly, Merck, Myriad Genetics, Novartis, Ondon.

Carey K. Anders, MD
Carey K. Anders, MD
Medical Director, Duke Center for Brain and Spine Metastasis
Translating Duke Health Scholar
Duke Cancer Institute
Professor of Medicine
Duke University
Durham, NC

Disclosures: Grant Research Support: G1 Therapeutics, Lilly, Nektar Therapeutics, Novartis, Pfizer, Puma Biotechnology, Seagen Inc., Tesaro, Zion Pharma; Consultant: AstraZeneca, Athenex, Elucida Oncology, Genentech, Immunomedics, Ipsen Biopharmaceuticals, Novartis, Seagen Inc.; Other Support: Royalties from UpToDate: Evidence-based Clinical Decision Support and Jones and Bartlett.

David M. Euhus, MD
David M. Euhus, MD
Professor of Surgical Oncology
John Hopkins University
Baltimore, MD

Disclosures: Grant Research Support: OMDOM Royalties for Cancer Gene Connect DSMB ALAPharma.

Ruth M. O'Regan, MD
Ruth M. O'Regan, MD
Chair, Department of Medicine
University of Rochester Medical Center
Charles A. Dewey Endowed Professor
Department of Medicine
University of Rochester
Rochester, NY

Disclosures: Consultant: BioDiagnostics, Immunomedics, Lilly, Novartis, Puma Biotechnology, Seagen Inc.

PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By